Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

A Next Generation Theranostic PSMA Ligand for 64Cu and67Cu-Based Prostate Cancer Imaging and Therapy

Shashikanth Ponnala, Alejandro Amor-Coarasa, James Kelly, Nicholas Zia, Williams Clarence, Anastasia Nikolopoulou, Paul Donnelly and John Babich
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1005;
Shashikanth Ponnala
6Radiology Weill Cornell Medicine New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro Amor-Coarasa
3Weill Cornell Medical College Bronx NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Kelly
5Weill Cornell Medicine New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas Zia
1University of Melbourne School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourn Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Williams Clarence
6Radiology Weill Cornell Medicine New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anastasia Nikolopoulou
6Radiology Weill Cornell Medicine New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Donnelly
2University of Melbourne Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Babich
4Weill Cornell Medical College New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 60 no. supplement 1 1005

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 21, 2019.

Copyright & Usage 
© 2019

Author Information

  1. Shashikanth Ponnala6,
  2. Alejandro Amor-Coarasa3,
  3. James Kelly5,
  4. Nicholas Zia1,
  5. Williams Clarence6,
  6. Anastasia Nikolopoulou6,
  7. Paul Donnelly2 and
  8. John Babich4
  1. 1University of Melbourne School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourn Melbourne Australia
  2. 2University of Melbourne Melbourne Australia
  3. 3Weill Cornell Medical College Bronx NY United States
  4. 4Weill Cornell Medical College New York NY United States
  5. 5Weill Cornell Medicine New York NY United States
  6. 6Radiology Weill Cornell Medicine New York NY United States

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2019 to April 2025

AbstractFullPdf
May 20191200
Jun 20194500
Jul 20193300
Aug 20192700
Sep 20196000
Oct 20195200
Nov 20194900
Dec 20193700
Jan 20202300
Feb 20202000
Mar 20204700
Apr 20203900
May 20202700
Jun 2020800
Jul 20201300
Aug 20202600
Sep 20201200
Oct 20202400
Nov 20201800
Dec 20201200
Jan 2021500
Feb 20211700
Mar 20211500
Apr 20211700
May 20212000
Jun 20212200
Jul 20212200
Aug 20212500
Sep 20211700
Oct 2021800
Nov 20212400
Dec 20212500
Jan 20222600
Feb 20221000
Mar 20221400
Apr 20223300
May 20222500
Jun 2022600
Jul 2022600
Aug 20221000
Sep 2022600
Oct 20221000
Nov 2022400
Dec 2022600
Jan 20231300
Feb 2023900
Mar 2023500
Apr 2023700
May 2023900
Jun 2023900
Jul 2023600
Aug 2023800
Sep 2023900
Oct 2023900
Nov 2023500
Dec 20231200
Jan 20241800
Feb 2024700
Mar 20241000
Apr 2024600
May 20241000
Jun 20242000
Jul 2024900
Aug 2024600
Sep 20241100
Oct 20241300
Nov 2024600
Dec 20241400
Jan 2025800
Feb 20251000
Mar 20251400
Apr 20251700
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Next Generation Theranostic PSMA Ligand for 64Cu and67Cu-Based Prostate Cancer Imaging and Therapy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
A Next Generation Theranostic PSMA Ligand for 64Cu and67Cu-Based Prostate Cancer Imaging and Therapy
Shashikanth Ponnala, Alejandro Amor-Coarasa, James Kelly, Nicholas Zia, Williams Clarence, Anastasia Nikolopoulou, Paul Donnelly, John Babich
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1005;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Next Generation Theranostic PSMA Ligand for 64Cu and67Cu-Based Prostate Cancer Imaging and Therapy
Shashikanth Ponnala, Alejandro Amor-Coarasa, James Kelly, Nicholas Zia, Williams Clarence, Anastasia Nikolopoulou, Paul Donnelly, John Babich
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1005;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • In vitro response of 177Lu-PSMA-617 with two different specific activities
  • Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
  • Synthesis and Preliminary Evaluation of Metabolically Stable 18F-Lableled PET Tracer for Fatty Acid Beta-Oxidation Imaging.
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Preclinical Probes for Oncology Posters

  • Targeted molecular imaging of c-Met in NSCLC using 68Ga-labeled binding peptide
  • A new PET imaging agent for monitoring HER2 status using Trastuzumab antibody conjugated with a novel 89 Zr-chelator.
Show more Preclinical Probes for Oncology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire